luxabendazole has been researched along with Fascioliasis in 2 studies
*Fascioliasis: Liver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorchilova, LN; Stoitsova, SR | 1 |
| Fok, E; Kassai, T; Redl, P; Takáts, C | 1 |
2 other study(ies) available for luxabendazole and Fascioliasis
| Article | Year |
|---|---|
Effects of luxabendazole on the tegument of Fasciola hepatica.
Topics: Acid Phosphatase; Animals; Anthelmintics; Benzimidazoles; Carbamates; Dose-Response Relationship, Drug; Fasciola hepatica; Fascioliasis; Histocytochemistry; Male; Microscopy, Electron; Rats; Rats, Wistar; Ruthenium Red | 1994 |
Activity of luxabendazole against liver flukes, gastrointestinal roundworms, and lungworms in naturally infected sheep.
Topics: Abomasum; Animals; Anthelmintics; Benzimidazoles; Carbamates; Dicrocoeliasis; Dictyocaulus Infections; Fasciola hepatica; Fascioliasis; Female; Helminthiasis; Helminthiasis, Animal; Intestinal Diseases, Parasitic; Intestine, Small; Liver; Nematode Infections; Random Allocation; Sheep; Sheep Diseases | 1988 |